Störmer, J.; Gwinner, W.; Derlin, K.; Immenschuh, S.; Rong, S.; Jang, M.-S.; Shushakova, N.; Haller, H.; Gueler, F.; Greite, R.
A Single Oral Dose of Diclofenac Causes Transition of Experimental Subclinical Acute Kidney Injury to Chronic Kidney Disease. Biomedicines 2022, 10, 1198.
https://doi.org/10.3390/biomedicines10051198
AMA Style
Störmer J, Gwinner W, Derlin K, Immenschuh S, Rong S, Jang M-S, Shushakova N, Haller H, Gueler F, Greite R.
A Single Oral Dose of Diclofenac Causes Transition of Experimental Subclinical Acute Kidney Injury to Chronic Kidney Disease. Biomedicines. 2022; 10(5):1198.
https://doi.org/10.3390/biomedicines10051198
Chicago/Turabian Style
Störmer, Johanna, Wilfried Gwinner, Katja Derlin, Stephan Immenschuh, Song Rong, Mi-Sun Jang, Nelli Shushakova, Hermann Haller, Faikah Gueler, and Robert Greite.
2022. "A Single Oral Dose of Diclofenac Causes Transition of Experimental Subclinical Acute Kidney Injury to Chronic Kidney Disease" Biomedicines 10, no. 5: 1198.
https://doi.org/10.3390/biomedicines10051198
APA Style
Störmer, J., Gwinner, W., Derlin, K., Immenschuh, S., Rong, S., Jang, M.-S., Shushakova, N., Haller, H., Gueler, F., & Greite, R.
(2022). A Single Oral Dose of Diclofenac Causes Transition of Experimental Subclinical Acute Kidney Injury to Chronic Kidney Disease. Biomedicines, 10(5), 1198.
https://doi.org/10.3390/biomedicines10051198
